Literature DB >> 15232678

The burden of hospitalised fractures in Sweden.

O Johnell1, J A Kanis, B Jonsson, A Oden, H Johansson, C De Laet.   

Abstract

The aim of this study was to characterise the hospital burden of fractures in the Swedish population by age and gender. The number of patients and number of fractures were documented according to site of fracture, age, sex and duration of hospital stay for the whole population of Sweden in 1996. Fractures were additionally classified as osteoporotic according to fracture site. In 1996 there were 54,000 admissions for fracture in men and women aged 50 years or more, accounting for 600,000 hospital-bed days. Hip fractures accounted for 63% of admissions for fracture in men and 72% in women, for 69% and 73% of hospital-bed days, respectively. Fractures considered to be osteoporotic accounted for 84% of all hospital-bed days due to fracture in men, and 93% in women. More hospital-bed days were due to osteoporotic fracture than to breast cancer and prostate cancer combined. The number of hospital-bed days due to osteoporotic fracture was between the amount due to ischaemic heart disease and the amount due to stroke.

Entities:  

Mesh:

Year:  2004        PMID: 15232678     DOI: 10.1007/s00198-004-1686-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  The burden of osteoporotic fractures: a method for setting intervention thresholds.

Authors:  J A Kanis; A Oden; O Johnell; B Jonsson; C de Laet; A Dawson
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  Non-constrained elbow arthroplasty for mutilans deformity in rheumatoid arthritis: a report of six cases.

Authors:  H Kudo
Journal:  J Bone Joint Surg Br       Date:  1998-03

3.  [Reliability of the hospital registry. The diagnostic data are better than their reputation].

Authors:  A C Nilsson; C L Spetz; K Carsjö; R Nightingale; B Smedby
Journal:  Lakartidningen       Date:  1994-02-16

4.  Age- and gender-specific rate of fractures in Australia: a population-based study.

Authors:  K M Sanders; E Seeman; A M Ugoni; J A Pasco; T J Martin; B Skoric; G C Nicholson; M A Kotowicz
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

Review 5.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

6.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  D M Kado; W S Browner; L Palermo; M C Nevitt; H K Genant; S R Cummings
Journal:  Arch Intern Med       Date:  1999-06-14

7.  Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study.

Authors:  K M Sanders; G C Nicholson; A M Ugoni; J A Pasco; E Seeman; M A Kotowicz
Journal:  Med J Aust       Date:  1999-05-17       Impact factor: 7.738

8.  Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland.

Authors:  K Lippuner; J von Overbeck; R Perrelet; H Bosshard; P Jaeger
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

9.  The apparent incidence of hip fracture in Europe: a study of national register sources.

Authors:  O Johnell; B Gullberg; E Allander; J A Kanis
Journal:  Osteoporos Int       Date:  1992-11       Impact factor: 4.507

10.  Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES).

Authors:  G Jones; T Nguyen; P N Sambrook; P J Kelly; C Gilbert; J A Eisman
Journal:  Osteoporos Int       Date:  1994-09       Impact factor: 4.507

View more
  34 in total

1.  Hip fracture and other predictors of anti-osteoporosis drug use in Norway.

Authors:  H M Devold; A J Søgaard; A Tverdal; J A Falch; K Furu; H E Meyer
Journal:  Osteoporos Int       Date:  2012-07-10       Impact factor: 4.507

2.  The global perspective of osteoporosis : the ILAR lecture, June 2004, Berlin.

Authors:  Anthony D Woolf
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

3.  Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry.

Authors:  C Bouza; T López; M Palma; J M Amate
Journal:  Osteoporos Int       Date:  2007-01-13       Impact factor: 4.507

4.  Requirements for DXA for the management of osteoporosis in Europe.

Authors:  J A Kanis; O Johnell
Journal:  Osteoporos Int       Date:  2004-12-24       Impact factor: 4.507

5.  Leisure time physical activity in adulthood is positively associated with bone mineral density 22 years later. The Tromsø study.

Authors:  Bente Morseth; Nina Emaus; Tom Wilsgaard; Bjarne K Jacobsen; Lone Jørgensen
Journal:  Eur J Epidemiol       Date:  2010-03-28       Impact factor: 8.082

Review 6.  Bone fragility in men--where are we?

Authors:  E Seeman; G Bianchi; S Khosla; J A Kanis; E Orwoll
Journal:  Osteoporos Int       Date:  2006-08-01       Impact factor: 4.507

7.  Hip fractures among elderly women: longitudinal comparison of physiological function changes and health care utilization.

Authors:  Yuchi Young; Linda P Fried; Yen-Hong Kuo
Journal:  J Am Med Dir Assoc       Date:  2010-01-06       Impact factor: 4.669

8.  Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Arch Osteoporos       Date:  2009-03-19       Impact factor: 2.617

9.  Bone Loss Rate May Interact with Other Risk Factors for Fractures among Elderly Women: A 15-Year Population-Based Study.

Authors:  Joonas Sirola; Anna-Kaisa Koistinen; Kari Salovaara; Toni Rikkonen; Marjo Tuppurainen; Jukka S Jurvelin; Risto Honkanen; Esko Alhava; Heikki Kröger
Journal:  J Osteoporos       Date:  2010-02-22

10.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.